Compare the Concentration of Exhaled Nitric Oxide in Patients With Different Severity of RF
Investigational drug(s) / intervention(s)
FeNO Observation
FeNO Observation: FeNO was observed and measured among patients with advanced respiratory support
Study summary
1. Main Objective: To compare the concentration of exhaled nitric oxide in patients with different severity of respiratory failure in ICU.
2. Secondary Purpose:
1. To observe the change of nitric oxide concentration in exhaled breath of patients with mechanical ventilation over time;
2. The relationship and differences between pulmonary ventilation blood flow levels in patients with different exhaled NO concentrations;
3. Reactivity of patients with different exhaled NO concentrations to inhaled nitric oxide therapy and the relationship between them.
Eligibility
Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
1. Adult patients (≥18 years of age) with mechanical ventilation or advanced respiratory support in the ICU, regardless of gender;
2. The expected mechanical ventilation time of tracheal intubation is more than 24 hours;
3. The initial ventilator Settings of clinical routine were adopted: oxygen fraction (FIO2) = 50%, respiratory rate = 15/min, positive end-expiratory pressure (PEEP) = 5 cmH2O, tidal volume = 6-8 ml/kg ideal body weight (IBW), inspiration-exhalation ratio =1:2;
4. Agree to participate in this experiment and sign the informed consent.
Exclusion Criteria:
* 1.Use of any NO-containing drugs (such as nitroglycerin), anti-inflammatory drugs, or drugs or means that affect the airway diameter within 6 hours before the first FeNO measurement; 2. Participating in other clinical research projects; 3. Patients deemed unsuitable by the investigators.
Primary outcome measure(s)
FeNO concentration — 1.5 year Exhaled nitric oxide concentration of patients with different severity of respiratory failure in ICU
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.